2019 DIA Editor’s Take – Advanced Clinical

Thought Leader:

Jason Casarella, Executive V.P., Business Development & Marketing, Advanced Clinical

July 19, 2019      

Jason Casarella talks about why it’s important for companies to embrace E6 (R2), which provides a unified standard for the European Union, Japan, and the United States to facilitate the mutual acceptance of clinical data by the regulatory authorities in these jurisdictions.

For more information please visit www.advancedclinical.com.

Post a Comment

You must be logged in to post a Comment.

FEEDBACK